Home › Funds › PNC Financial Services › ANVS
PNC Financial Services position in ANVS
ANNOVIS BIO INC · Health Care
Latest position (Q2 2026)360 sh
Reported value held$670
Portfolio Weight0.00%
First reportedQ1 2025
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 360 | $540 | New |
| Q2 2025 | 360 | $781 | Hold |
| Q3 2025 | 360 | $745 | Hold |
| Q4 2025 | 360 | $1.25K | Hold |
| Q1 2026 | 360 | $803 | Hold |
| Q2 2026 | 360 | $670 | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANVS
- Marshall Wace 1.84M sh · $3.43M · Q2 2026
- Vanguard Group 923.20K sh · $3.19M · Q4 2025
- Renaissance Technologies 1.00M sh · $1.86M · Q2 2026
- Two Sigma Investments 579.57K sh · $1.08M · Q2 2026
- Geode Capital Management 283.82K sh · $528.13K · Q2 2026
- BlackRock Inc 249.86K sh · $464.73K · Q2 2026
- Citadel Advisors 114.80K sh · $213.53K · Q2 2026
- Northern Trust Corp 68.07K sh · $126.61K · Q2 2026
- Wells Fargo & Co 30.31K sh · $56.37K · Q2 2026
- Millennium Management 23.46K sh · $43.64K · Q2 2026
- BNY Mellon 15.48K sh · $28.79K · Q2 2026
- JPMorgan Chase & Co 15.22K sh · $28.31K · Q2 2026